Ara
Toplam kayıt 266, listelenen: 41-50
Folic Acid: A New Weapon for Mucositis?
(Cig Media Group, Lp, 2019)
[No abstract available]
Electroconvulsive Therapy and Anticoagulation
(Elsevier Science Inc, 2019)
[No abstract available]
Parapharyngeal Space Lipoma
(Lippincott Williams & Wilkins, 2015)
Letter to the Editor
Comments on "patient-reported joint status and quality of life in sports-related ankle disorders and osteoarthritis"
(Springer, 2020)
This is an important procedure for the level of evidence of the study. Therefore, it is also important to state whether the Slovenian version is used or not. I would welcome the comments of the authors to address these ...
Hyperbaric oxygen treatment resistant carbon monoxide poisoning
(Elsevier Science Inc, 2019)
The article entitled“Hyperbaric oxygen treatment resistant carbonmonoxide poisoning”by Gulcin Aydin reports a patient who could notbenefit from Hyperbaric Oxygen Treatment (HBOT) [1]. I would like toemphasise some issues ...
Reaction time and functional balance in chronic obstructive pulmonary disease
(Mosby-Elsevier, 2020)
We read with great interest the article recently published by Singh et al. entitled “Comparison of reaction time and functional balance in
chronic obstructive pulmonary disease and healthy participants
Comments on "Translation, cross-cultural adaptation, validation, and measurement properties of the Spanish version of the anterior cruciate ligament-return to sport after injury (ACL-RSI-Sp) Scale"
(Springer, 2020)
The purpose of the study was to evaluate the psychometric properties of the survey. While I believe the authors have made a considerable contribution to this work, there are some concerns that I would like to address. ...
Bucillamine-induced Pneumonitis in a Patient with Rheumatoid Arthritis-associated Interstitial Pneumonia: A Case Report and Review of the Literature
(Japan Soc Internal Medicine, 2019)
[No abstract available]
Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers
(Mosby-Elsevier, 2019)
Correspondence
Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
(Humana Press Inc, 2020)
As we know more about the clinical and laboratory features of COVID-19, which is now accepted as a pandemic, many questions have been raised about how to manage and monitor the treatment of cancer patients. It was determined ...